101
Participants
Start Date
January 31, 2015
Primary Completion Date
October 15, 2021
Study Completion Date
April 15, 2022
Placebo GABA and Placebo GAD-alum
Maltodextrin as a placebo formulation for GABA Placebo GAD-alum injection
GABA and Placebo GAD-alum
Oral Active GABA with Placebo GAD-alum
Active Oral GABA and Active GAD-alum injection
Active Oral GABA and Active GAD-alum injection
Children's of Alabama, Birmingham
Collaborators (2)
Diamyd Inc
INDUSTRY
NOW Foods
OTHER
Janssen Pharmaceuticals
INDUSTRY
Juvenile Diabetes Research Foundation
OTHER
University of Alabama at Birmingham
OTHER